合并COVID-19的急诊普通外科患者死亡率与肺部并发症:一项大型国际多中心研究
该国际多中心研究纳入52个国家361家医院中2020年2月至7月术前确诊COVID-19、年龄17岁及以上并接受急诊普通外科手术(阑尾切除术、胆囊切除术或开腹术)的1045例患者,主要终点为30天死亡率和30天肺部并发症(急性呼吸窘迫综合征、非预期机械通气或肺炎的复合终点)。总体死亡率为15.1%(158/1045),总体肺部并发症率为32.9%(344/1045);开腹手术亚组中分别为30.6%(134/438)和59.2%(260/439)。亚组分析发现术前有呼吸道表现的患者死亡和肺部并发症风险尤其升高。作者结论认为合并COVID-19的急诊普通外科患者死亡率和肺部并发症率显著升高,风险在术前有呼吸道表现者中最为突出。
要点
- 总体30天死亡率为15.1%(158/1045),总体30天肺部并发症率为32.9%(344/1045)。
- 开腹手术患者30天死亡率为30.6%(134/438),肺部并发症率为59.2%(260/439)。
- 亚组分析显示术前有COVID相关呼吸道表现者死亡和肺部并发症风险尤其升高。
- 共纳入1045例患者,其中女性占40.1%,50岁以上占50.0%。
适用人群与场景
- 年龄17岁及以上、术前确诊COVID-19(2020年2月至7月)并接受急诊普通外科手术(阑尾切除术、胆囊切除术或开腹术)的患者。
诊断标准与关键阈值
- 急诊普通外科手术定义为紧急/急症实施阑尾切除术、胆囊切除术或开腹术。
- 术前COVID相关呼吸道表现包括咳嗽、呼吸困难、需要氧疗、胸部影像学异常。
研究设计与关键结果
- 研究类型为国际多中心研究,纳入52个国家361家医院的1045例患者;女性占40.1%,50岁以上占50.0%。
- 手术类型:阑尾切除术461例(44.1%)、胆囊切除术145例(13.9%)、开腹术439例(42.0%)。
- 总体30天死亡率为15.1%(158/1045),总体30天肺部并发症率为32.9%(344/1045)。
- 开腹手术亚组30天死亡率为30.6%(134/438),肺部并发症率为59.2%(260/439)。
- 亚组分析发现术前有呼吸道表现的患者死亡和肺部并发症风险尤其升高。
证据类型、等级与局限
- 证据类型:预后与流行病学研究;证据等级:Level IV。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为合并COVID-19的急诊普通外科患者死亡率和肺部并发症率显著升高,风险在术前有呼吸道表现者中最为突出。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The outcomes of emergency general surgery (EGS) patients with concomitant COVID-19 infection remain unknown. With a multicenter study in 361 hospitals from 52 countries, we sought to study the mortality and pulmonary complications of COVID-19 patients undergoing EGS.
METHODS: All patients 17 years or older and diagnosed preoperatively with COVID-19 between February and July 2020 were included. Emergency general surgery was defined as the urgent/emergent performance of appendectomy, cholecystectomy, or laparotomy. The main outcomes were 30-day mortality and 30-day pulmonary complications (a composite of acute respiratory distress syndrome, unexpected mechanical ventilation, or pneumonia). Planned subgroup analyses were performed based on presence of preoperative COVID-related respiratory findings (e.g., cough, dyspnea, need for oxygen therapy, chest radiology abnormality).
RESULTS: A total of 1,045 patients were included, of which 40.1% were female and 50.0% were older than 50 years; 461 (44.1%), 145 (13.9%), and 439 (42.0%) underwent appendectomy, cholecystectomy, and laparotomy, respectively. The overall mortality rate was 15.1% (158 of 1,045 patients), and the overall pulmonary complication rate was 32.9% (344 of 1,045 patients); in the subgroup of laparotomy patients, the rates were 30.6% (134 of 438 patients) and 59.2% (260 of 439 patients), respectively. Subgroup analyses found mortality and pulmonary complication risk to be especially increased in patients with preoperative respiratory findings.
CONCLUSION: COVID-19 patients undergoing EGS have significantly high rates of mortality and pulmonary complications, but the risk is most pronounced in those with preoperative respiratory findings.
LEVEL OF EVIDENCE: Prognostic and Epidemiologic; Level IV.
参考来源
- Mortality and pulmonary complications in emergency general surgery patients with COVID-19: A large international multicenter study. J Trauma Acute Care Surg. 2022. PMID: 35195098. doi:10.1097/TA.0000000000003577
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。